‘Bionic Pancreas’ Tested in San Antonio Adapts to Type 1 Diabetes Patients’ Needs
Fifteen-year-old Mia Campos is living with Type 1 diabetes and can now enjoy everyday activities without any limitations thanks to her new "bionic pancreas."
Campos's new “bionic pancreas” is a wearable, electronic device that replaces the role of her pancreas and adapts to the needs of her endocrine system over time. Campos was one of 17 San Antonio children who were chosen to participate in a study to develop the iLet Insulin Bionic Pancreas system. This new system uses the information from the continuous glucose monitor and nutrition data to automate the insulin pump, adapt to the patient's insulin needs and work as a pancreas to manage the patient's glucose levels.
Mia Campos, 15, says the iLet Insulin Bionic Pancreas device has given her more freedom and the ability to do some activities that were difficult before. Credit: Scott Ball / San Antonio Report
The iLet Insulin system was developed by Massachusetts-based Beta Bionics and is one of many new advances in diabetes management technology which are improving ways to automate insulin delivery.
The system uses input from the continuous glucose monitor and nutrition data to automate the insulin pump, adapting to the patient’s insulin needs and working as a pancreas to manage a patient’s glucose levels.
It stands out from other insulin pump systems through three levels of automation by using three artificial intelligence-based algorithms: One for background insulin, correction for high blood sugar and meal announcements.
Read more about this exciting development for those with Type 1 diabetes in the San Antonio Report, https://sanantonioreport.org/san-antonio-ilet-insulin-bionic-pancreas-test-type-1-diabetes/